Clinical Research and Personalized Medicine in Inflammatory Bowel Disease
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 41
Special Issue Editors
Interests: gastroenterology; inflammatory bowel diseases; gut microbiota; cardiovascular risk in IBD; GI endoscopy
Interests: gastroenterology; inflammatory bowel diseases; gut microbiota; GI endoscopy; gut immunology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit your manuscript to the Journal of Clinical Medicine for consideration for a Special Issue entitled “Clinical Research and Personalized Medicine in Inflammatory Bowel Disease".
Over the last several decades, advances in clinical research, immunology, and precision medicine have transformed our understanding of the pathogenesis of IBD, leading to more targeted and individualized treatment approaches. However, despite this progress, many questions remain unanswered regarding disease progression, therapeutic responses, and patient-specific factors influencing outcomes.
This Special Issue, “Clinical Research and Personalized Medicine in Inflammatory Bowel Disease”, will provide a comprehensive platform for innovative research aimed at improving our ability to tailor treatments to individual patients. With the rise in genomics, microbiome analysis, and artificial intelligence in healthcare, we are at a pivotal moment in the evolution of IBD management. This Special Issue will explore novel diagnostic tools, predictive biomarkers, patient stratification strategies, and innovative therapeutic interventions, bridging the gap between research and clinical applications.
We invite original research articles and reviews that contribute to this growing field. Topics of interest include, but are not limited to, the following:
- Advances in the genetic and molecular mechanisms underlying IBD;
- The role of the gut microbiome in disease progression and therapy response;
- Biomarker-driven approaches to personalized treatment strategies;
- Machine learning and AI applications in predicting treatment outcomes;
- Novel biologics, small molecules, and combination therapies for IBD;
- Patient-reported outcomes and real-world data in personalized medicine.
We look forward to receiving your valuable contributions and advancing the science behind personalized medicine in IBD together.
Dr. Alfredo Papa
Dr. Loris Riccardo Lopetuso
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel disease (IBD)
- personalized medicine
- precision medicine
- Crohn’s disease
- ulcerative colitis
- targeted therapy
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
